Formulary Decisions
Search for the outcome of decisions made by the Formulary Committee
Indication
Alone or in combination with methotrexate, for the treatment of active psoriatic arthritis in adult patients when the response to previous disease-modifying anti-rheumatic drug (DMARD) therapy has been inadequate.
Therapeutic Area
Musculoskeletal and joint diseases
Status Description
Routinely available in line with national guidance
Formulation
150mg solution for injection in pre-filled pen and pre-filled syringe
Comments
November 2016 - Included on the LJF as first choice, Specialist Use only, for the indication in question. May 2017 - NICE MTA advice: SMC advice 1167/16 is superseded by NICE TA445. July 2019 (as per LJF) - Routinely available in line with national guidance. Included on the Additional List, for Specialist Use only.
Link to Advice
Advice Published
24/05/2017